Becker's Healthcare September 9, 2024
Insurers and employers face ongoing challenges in covering costly GLP-1 medications, with coverage rates varying significantly based on the individual’s insurance plan and employer.
Becker’s has gathered the latest research and analysis on weight loss drug policies to offer insight into current coverage trends.
10 key numbers:
1. Among U.S. adults, 80% say insurers should cover weight loss drugs for adults diagnosed as overweight or obese, according to an August 2023 survey from KFF. Half of respondents also said insurance should cover the drugs even if it would increase premium costs.
2. Over 42% of U.S. adults (57.4 million) under 65 with private insurance could be eligible for GLP-1 drugs, based on current FDA indications, according to a Sept....
Today's Sponsors
Today's Sponsor